Julie L. Sutcliffe, Ph.D.

New research is offering some hope in the fight against pancreatic cancer.

The answer is nuclear medicine. And the power to find cancer and deliver therapy all at the same time. Theranostics, combining therapy and diagnostics, is a promising approach to cancer treatment.

While some people fear the idea of using radioactive isotopes as a therapy in the body, Julie Sutcliffe PhD. knows the power for good.

“You have a molecule, same molecule with a different piece of radioactivity on it, so one is for imaging for diagnostics, one is for therapy for treatment,” she said. “So theranostics combine the two words together… Continue reading.

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Julie L. Sutcliffe, Ph.D., to its College of Fellows. Dr. Sutcliffe was nominated, reviewed, and elected by peers and members of the College of Fellows for outstanding leadership in molecular imaging and translational sciences and leading technology from the bench to the clinic.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences… Continue reading.